VTGN

Conviction 0HealthcareScan · Mon, Aug 10, 2026

VTGN$0.2636-8.34%

ResistanceSupportVol 14

Vol MA14 9.97M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Vistagen Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.vistagen.com ↗

Price0.2636

Change-8.34%

Gap+0.94%

Rel volume0.21×

Avg volume7.19M

Avg $ vol2.11M

SMA 200.2491

SMA 500.4022

SMA 2001.26

Price vs 50-34.47%

Price vs 200-79.16%

MA stackbearish

50/200 cross—

Supertrenddown · 0.3216

RSI (14)42

MACD hist0.02

MACD cross—

Stoch %K / %D45 / 60

ADX (14)24

+DI / −DI23 / 23

RSI divergence—

MACD divergence—

ATR %+13.11%

ADR %8.01%

52w high4.90

52w low0.2260

From 52w high-94.62%

Above 52w low+16.64%

New 52w highNo

SqueezeOff

Bollinger width37.45%

%B0.66

Donchian pos45.24%

Donchian high0.3200

Donchian low0.2170

AVWAP (52w high)0.6232

vs AVWAP high-57.70%

AVWAP (52w low)0.2676

vs AVWAP low-1.51%

OBV trendUp

Chaikin MF (20)0.27

Today vs 20d0.21×

Avg vol (14d)9.97M

Avg vol (20d)7.19M

Avg $ vol (20d)2.11M

Market cap10.82M

RS 3m (vs SPY)-56.69%

RS 6m (vs SPY)-57.16%

RS line new highNo

Trend template0/8

Technical rank13.8

1 week+7.59%

1 month+2.17%

3 months-56.82%

6 months-53.20%

1 year-90.34%

YTD-61.18%

P/E-0.16

P/B0.30

P/S-47.65

P/FCF-0.16

EPS-1.83

Div yield—

ROE-196.19%

ROA-143.49%

Debt/Eq-0.04

Current3.67

EV/EBITDA0.30

Gross margin—

Net margin—

Rev growth-120.47%

EPS growth-35.53%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-21.48M

Revenue354.1K

Net income-18.9M

Gross profit—

Free cash flow-66.64M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out39.62M

Employees59

ListedWed, Jul 1, 2009

Free float38.46M

Float %97.1%

Short interest1.6M

Days to cover0.5d

Short volume43.8%

Squeeze score13 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank13.8 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.7649

Support0.2075

Days since event—

Candle confirm—

News sentiment—

Financials as of Wed, Dec 31, 2025 · quarterly.

Congress activity

Disclosed STOCK Act trades in VTGN

All disclosures →

No recent disclosed trades by Congress in VTGN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VTGN · 9 buys

Insider	Side	Shares	Value	Traded	Filed
Angelov Angel S Chief Medical Officer · Stock Option (Right to Buy) · 2026-05-18	Grant	150K	—	2026-05-18	2026-05-19
Singh Shawn President and CEO · Non-Qualified Stock Option (right to buy) · 2026-04-07	Grant	71.27K	$0	2026-04-07	2026-04-09
Adler Reid G. Chief Legal Officer · Incentive Stock Option (right to buy) · 2026-04-07	Grant	18.75K	$0	2026-04-07	2026-04-09
Tressler Nick B. Chief Financial Officer · Incentive Stock Option (right to buy) · 2026-04-07	Grant	75K	$0	2026-04-07	2026-04-09
Cote Elissa S. Chief Corp Development Officer · Incentive Stock Option (right to buy) · 2026-04-07	Grant	75K	$0	2026-04-07	2026-04-09
Singh Shawn President and CEO · Incentive Stock Option (right to buy) · 2026-04-07	Grant	3.73K	$0	2026-04-07	2026-04-09
Adler Reid G. Chief Legal Officer · Non-Qualified Stock Option (right to buy) · 2026-04-07	Grant	56.25K	$0	2026-04-07	2026-04-09
Prince Joshua S. Chief Operating Officer · Non-Qualified Stock Option (right to buy) · 2026-04-07	Grant	56.25K	$0	2026-04-07	2026-04-09
Prince Joshua S. Chief Operating Officer · Incentive Stock Option (right to buy) · 2026-04-07	Grant	18.75K	$0	2026-04-07	2026-04-09

SEC filings

EDGAR filings in VTGN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.